• Sabina M Janciauskiene, Robert Bals, Rembert Koczulla, Claus Vogelmeier, Thomas Köhnlein, and Tobias Welte.
• Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany. Janciauskiene.Sabina@mh-hannover.de
• Respir Med. 2011 Aug 1;105(8):1129-39.

Abstractα1-Antitrypsin (AAT) is the archetype member of the serine protease inhibitor (SERPIN) supergene family. The AAT deficiency is most often associated with the Z mutation, which results in abnormal Z AAT folding in the endoplasmic reticulum of hepatocytes during biogenesis. This causes intra-cellular retention of the AAT protein rather than efficient secretion with consequent deficiency of circulating AAT. The reduced serum levels of AAT contribute to the development of chronic obstructive pulmonary disease (COPD) and the accumulation of abnormally folded AAT protein increases risk for liver diseases. In this review we show that with the discovery of AAT deficiency in the early 60s as a genetically determined predisposition to the development of early-onset emphysema, intensive investigations of enzymatic mechanisms that produce lung destruction in COPD were pursued. To date, the role of AAT in other than lung and liver diseases has not been extensively examined. Current findings provide new evidence that, in addition to protease inhibition, AAT expresses anti-inflammatory, immunomodulatory and antimicrobial properties, and highlight the importance of this protein in health and diseases. In this review co-occurrence of several diseases with AAT deficiency is discussed.Copyright © 2011 Elsevier Ltd. All rights reserved.

15 keywords...

hide…